The Lancet Respiratory Medicine in conversation with
Ein Podcast von The Lancet Group
156 Folgen
-
Inhaled budesonide in the treatment of early COVID-19
Vom: 15.4.2021 -
Tocilizumab and COVID-19
Vom: 5.3.2021 -
Interferon treatment and COVID-19
Vom: 6.2.2021 -
Evaluating deterioration in patients with acute COVID-19
Vom: 12.1.2021 -
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Vom: 5.1.2021 -
COVID-19 and severe influenza
Vom: 18.12.2020 -
The second wave and homeless populations
Vom: 11.11.2020 -
Corticosteroids, COPD, asthma and COVID-19
Vom: 25.9.2020 -
Novel strategies to drive down the global burden of asthma
Vom: 8.9.2020 -
The pathology of suspected EVALI
Vom: 5.8.2020 -
Wheezing illness and RSV-LRTI
Vom: 17.7.2020 -
Antibiotic use in infancy and asthma incidence
Vom: 16.3.2020 -
Guidance on the development of prediction models for critical care
Vom: 12.3.2020 -
Potential exacerbations in patients with COPD
Vom: 3.3.2020 -
CPAP and mild obstructive sleep apnea
Vom: 28.11.2019 -
An algorithm for EVALI
Vom: 8.11.2019 -
Lung transplants from Hepatitis C viremic donors
Vom: 5.10.2019 -
Looking to the future of cystic fibrosis care
Vom: 29.9.2019 -
Pamrevlumab and idiopathic pulmonary fibrosis
Vom: 27.9.2019 -
Nicotine patches, e-cigarettes, and smoking cessation
Vom: 10.9.2019
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
